Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biomarin Pharmaceutical Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BMRN
Nasdaq
2834
https://www.biomarin.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biomarin Pharmaceutical Inc
Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
- Apr 25th, 2024 10:46 am
Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...
- Apr 25th, 2024 7:19 am
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- Apr 24th, 2024 10:30 pm
BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates
- Apr 24th, 2024 9:33 pm
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
- Apr 24th, 2024 9:15 pm
BioMarin Reports Record Financial Results for the First Quarter 2024
- Apr 24th, 2024 8:03 pm
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
- Apr 23rd, 2024 3:36 pm
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
- Apr 23rd, 2024 1:58 pm
BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says
- Apr 22nd, 2024 8:26 pm
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
- Apr 22nd, 2024 1:16 pm
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
- Apr 18th, 2024 2:01 pm
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 17th, 2024 2:01 pm
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
- Apr 12th, 2024 11:00 pm
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
- Apr 10th, 2024 12:00 pm
Insider Sell: EVP, Chief Legal Officer George Davis Sells 24,602 Shares of Biomarin ...
- Apr 1st, 2024 11:01 pm
Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?
- Mar 28th, 2024 3:30 pm
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
- Mar 16th, 2024 9:06 am
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
- Mar 12th, 2024 12:30 pm
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
- Mar 11th, 2024 2:00 pm
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...
- Mar 8th, 2024 6:31 am
Scroll